Dr. Nisarg Thakkar

Oncology, Haematology
A) Benign Hematological Disorders • All types of Anemia • Hemolytic Anemias (AIHA, PNH, HS, G6PD deficiency etc) • Hemoglobinopathies like Thalessemia & Sickle cell anemia • Low platelet counts like ITP • High Hb, high WBC, high platelet counts • Bleeding disorders like Hemophilias, VWD • Thrombosis like DVT, PE and CVST • Acquired Bone marrow failure syndromes like Aplastic anemia and MDS • Congenital BM failure syndromes like Fanconi anemia • Primary Immunodeficiency Disorders (PIDs) B) Malignant Hematological Disorders (Blood cancers) • All types of Acute Leukemia • All types of Lymphomas • CMPNs like CML, PV, ET and PMF • Multiple Myeloma and Amyloidosis C) Bone marrow/Stem cell transplant • Autologous stem cell transplant • Allogenic stem cell transplant (MRD, Haplo and MUD)
MBBS,MD,DrNB (Clinical Haematology)
4
0281-6694244
Monday, Tuesday, Wednesday, Thursday, Friday, Saturday

Monday: Morning 10:00 am to 01:00 pm Evening 05:30 pm to 06:30 pm

Tuesday: Morning 10:00 am to 01:00 pm Evening 05:30 pm to 06:30 pm

Wednesday: Morning 10:00 am to 01:00 pm Evening 05:30 pm to 06:30 pm

Thursday: Morning 10:00 am to 01:00 pm Evening 05:30 pm to 06:30 pm

Friday: Morning 10:00 am to 01:00 pm Evening 05:30 pm to 06:30 pm

Saturday: Morning 10:00 am to 01:00 pm Evening 05:30 pm to 06:30 pm

“Early prediction of thrombosis in patients with malignancy: Role TEG versus conventional coagulation parameters” Dissertation submitted and accepted by National board of examination

“Evaluation of etiology, severity and prognosis of thrombocytopenia in various common infections at tertiary care centre” dissertation submitted and accepted Rajasthan University of Health & Sciences, Jaipur

Acknowledgment received by Dr. Sanjeev Sharma, senior consultant hematologist at New Delhi to support in his book: Postgraduate review series- mcqs in Hematology, 2nd edition.

Presentation: “How I establish bone marrow transplant unit” in YHOP at SGPGI, Lucknow.

A Single-Arm, Multicenter Phase IIIB Clinical Trial to evaluate the safety and tolerability of prophylactic Emicizumab in Hemophilia A patients with inhibitors

A phase III randomised open label multi centre study of ruxolitinib vs. best available therapy in patients with corticosteroid refractory chronic graft versus host disease after allogenic stem cell transplantation

A prospective, multicenter, randomise, double blind study to compare the efficacy and safety of ENZ110 (similar biologic of romiplostim) versus innovator romiplostim in patients with chronic ITP

MBBS from Pramukh Swami Medical College,Karamsad,Gujarat (2006-2011)

MD Medicine from Sawai Man Singh Medical College,Jaipur (2013-2016)

DrNB(Doctorate of National Board) Clinical Haematology from Sahyadri Super Specialiy Hospital,Pune (2018-2021)

Senior Registrar in Department of Clinical Hematology and BMT unit at B L Kapur Super

Specialty Hospital, New Delhi for 9 months – Senior Registrar In Department of Clinical Hematology and BMT unit at Sahyadri Super

Specialty Hospital Pune for 3.5 years

Diagnosed and treated more than 2000 patients having simple to complex hematological disorders

Has given Chemotherapy, Immunotherapy and Targeted Therapy

Around 200 Peripheral Blood Stem Cell Transplants/Bone Marrow Transplants done under

supervision including Autologous and Allogenic transplants